U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H23FN4OS.2ClH
Molecular Weight 459.408
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PHORTRESS

SMILES

Cl.Cl.CC1=C(NC(=O)[C@@H](N)CCCCN)C=CC(=C1)C2=NC3=C(S2)C=CC(F)=C3

InChI

InChIKey=QZSMNTOCJVVFEU-CKUXDGONSA-N
InChI=1S/C20H23FN4OS.2ClH/c1-12-10-13(20-25-17-11-14(21)6-8-18(17)27-20)5-7-16(12)24-19(26)15(23)4-2-3-9-22;;/h5-8,10-11,15H,2-4,9,22-23H2,1H3,(H,24,26);2*1H/t15-;;/m0../s1

HIDE SMILES / InChI

Molecular Formula C20H23FN4OS
Molecular Weight 386.486
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 11:18:26 UTC 2023
Edited
by admin
on Sat Dec 16 11:18:26 UTC 2023
Record UNII
AXR52N9SMF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PHORTRESS
Common Name English
NSC-710305
Code English
5F-DF-203-L-LYSINAMIDE DIHYDROCHLORIDE
Common Name English
HEXANAMIDE, 2,6-DIAMINO-N-(4-(5-FLUORO-2-BENZOTHIAZOLYL)-2-METHYLPHENYL)-, HYDROCHLORIDE (1:2), (2S)-
Systematic Name English
(2S)-2,6-DIAMINO-N-(4-(5-FLUORO-1,3-BENZOTHIAZOL-2-YL)-2-METHYL-PHENYL)HEXANAMIDE HYDROCHLORIDE
Systematic Name English
Code System Code Type Description
CAS
328087-38-3
Created by admin on Sat Dec 16 11:18:26 UTC 2023 , Edited by admin on Sat Dec 16 11:18:26 UTC 2023
PRIMARY
MANUFACTURER PRODUCT INFORMATION
5F-DF-203-L-LYSINAMIDE
Created by admin on Sat Dec 16 11:18:26 UTC 2023 , Edited by admin on Sat Dec 16 11:18:26 UTC 2023
PRIMARY Substd. 2-arylbenzazole cpds. and their use as antitumour agents.
EVMPD
SUB194064
Created by admin on Sat Dec 16 11:18:26 UTC 2023 , Edited by admin on Sat Dec 16 11:18:26 UTC 2023
PRIMARY
PUBCHEM
9804228
Created by admin on Sat Dec 16 11:18:26 UTC 2023 , Edited by admin on Sat Dec 16 11:18:26 UTC 2023
PRIMARY
MANUFACTURER PRODUCT INFORMATION
PHORTRESS
Created by admin on Sat Dec 16 11:18:26 UTC 2023 , Edited by admin on Sat Dec 16 11:18:26 UTC 2023
PRIMARY Phortress rapidly reverts to 5-fluoro 203 in carcinoma cell lines, resulting in significant growth inhibition at nanomolar concentrations.2 At 20 mg/kg, phortress can suppress the growth of breast and ovarian xenografts in vivo.
NSC
710305
Created by admin on Sat Dec 16 11:18:26 UTC 2023 , Edited by admin on Sat Dec 16 11:18:26 UTC 2023
PRIMARY
SMS_ID
100000178336
Created by admin on Sat Dec 16 11:18:26 UTC 2023 , Edited by admin on Sat Dec 16 11:18:26 UTC 2023
PRIMARY
FDA UNII
AXR52N9SMF
Created by admin on Sat Dec 16 11:18:26 UTC 2023 , Edited by admin on Sat Dec 16 11:18:26 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY
In 2002, DDG approved the development of Phortress as a clinical candidate and provided synthesis, formulation, pharmacokinetic, and toxicity resources.